Cameron C Trenor's most recent trade in AN2 Therapeutics Inc was a trade of 233,333 Stock Option (right to by) done . Disclosure was reported to the exchange on Sept. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AN2 Therapeutics Inc | Cameron C Trenor | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 233,333 | 233,333 | - | - | Stock Option (right to by) | |
| AN2 Therapeutics Inc | Cameron C Trenor | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 116,667 | 116,667 | - | 0 | Common Stock |